

A retrospective chart review of opioid-induced nausea and somnolence on commencement for cancer pain treatment
Abstract
Keywords
References
Davis MP, Walsh D: Treatment of nausea and vomiting in advanced cancer. Support Care Cancer. 2000; 8(6): 444-452.
Mannix K: Palliation of nausea and vomiting in malignancy. Clin Med. 2006; 6(2): 144-147.
Teunissen SC, Wesker W, Kruitwagen C, et al.: Symptom prevalence in patients with incurable cancer: A systematic review. J Pain Symptom Manage. 2007; 34(1): 94-104.
Cherny NI: Opioid analgesics: Comparative features and prescribing guidelines. Drugs. 1996; 51(5): 713-737.
De Conno F, Ripamonti C, Fagnoni E, et al.: The MERITO Study: A multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during ‘titration phase’ in patients with cancer pain. Palliat Med. 2008; 22(3): 214-221.
Suzuki T, Morishita M, Ito E, et al.: Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer. Am J Ther. 2008; 15(1): 31-35.
Yu SY: Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain. Oncology. 2008; 74 (Suppl 1): 46-51.
Bentley A, Boyd K: Use of clinical pictures in the management of nausea and vomiting: A prospective audit. Palliat Med. 2001; 15(3): 247-253.
Heiskanen T, Kalso E: Controlled-release oxycodone and morphine in cancer related pain. Pain. 1997; 73(1): 37-45.
Nugent M, Davis C, Brooks D, et al.: Long-term observations of patients receiving transdermal fentanyl after a randomized trial. J Pain Symptom Manage. 2001; 21(5): 385-391.
Tassinari D, Sartori S, Tamburini E, et al.: Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: A meta-analysis and systematic review of the literature. J Palliat Med. 2008; 11(3): 492-501.
Twycross R (ed.): Oral Morphine, Pain Relief in Advanced Cancer. London: Churchill Livingstone, 1998.
Shord SS, Chew L, Villano J: Evaluation of opioid induced nausea and vomiting in sickle cell disease. Am J Hematol. 2008; 83(3): 196-199.
Twycross R, Wilcock A: Palliative Care Formulary. 3rd ed. UK: Palliativedrugs.com Ltd., 2007.
Carr BI, Blayney DW, Goldberg DA, et al.: High doses of prochlorperazine for cisplatin-induced emesis. A prospective, random, dose-response study. Cancer. 1987; 60(9): 2165-2169.
Tsuji Y, Miyama S, Uemura Y, et al.: Three cases of drug-induced akathisia due to antiemetics during cancer palliative care. Gan To Kagaku Ryoho. 2006; 33(2): 267-269.
Sunakawa Y, Wada M, Nishida T, et al.: A case of respiratory akathisia in a cancer patient: A case report. Palliat Support Care. 2008; 6(1): 79-81.
Ahmedzai S, Brooks D: Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage. 1997; 13(5): 254-261.
Nigel Sykes MB, Yuan C-S (ed.): Clinical Pain Management Cancer Pain. 2nd ed. London: Mixed Sources, 2008.
Eduardo Bruera IJH, Ripamonti C, Gunten C (ed.): Textbook of Palliative Medicine. New York: Oxford University Press, 2006.
DOI: https://doi.org/10.5055/jom.2010.0041
Refbacks
- There are currently no refbacks.